Beractant Phospholipids: Side Effects, Uses & Monitoring
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
- Data source
- FDA labeling via NIH DailyMed (label 7ef9e3a5…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Apnea | 65.4% |
| Intracranial hemorrhage | 48.1% |
| Patent ductus arteriosus | 47.1% |
| Severe apnea | 46.1% |
| Pulmonary interstitial emphysema | 38.4% |
| Pulmonary air leaks | 24.7% |
| Severe intracranial hemorrhage | 24.1% |
| Post-treatment sepsis | 20.7% |
| Post-treatment infection | 10.2% |
| Pulmonary hemorrhage | 7.2% |
| Necrotizing enterocolitis | 6.1% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
Frequently Asked Questions
What is Beractant Phospholipids used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Beractant Phospholipids?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Beractant Phospholipids. Individual risk varies.
Does Beractant Phospholipids require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Beractant Phospholipids.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.